169331-42-4

Basic information

• Product Name: βS--αR-<<(2-methylpropyl)amino>methyl>-benzenepropanol
• Synonyms: βS--αR-<<(2-methylpropyl)amino>methyl>-benzenepropanol
• CAS NO: 169331-42-4
• Molecular Weight: 416.607
• Mol File: 169331-42-4.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: βS--αR-<<(2-methylpropyl)amino>methyl>-benzenepropanol(CAS DataBase Reference)
• NIST Chemistry Reference: βS--αR-<<(2-methylpropyl)amino>methyl>-benzenepropanol(169331-42-4)
• EPA Substance Registry System: βS--αR-<<(2-methylpropyl)amino>methyl>-benzenepropanol(169331-42-4)

Safety Data

• Hazardous Substances Data: 169331-42-4(Hazardous Substances Data)

Upstream product

• 78-81-9 isobutylamine 
• 127943-39-9 (1R)-[1'(S)-(dibenzylamino)-2'-phenylethyl]oxirane 
• 127927-43-9 N,N-dibenzyl-3(S)-amino-1,2(S)-epoxy-4-phenylbutane 
• 95437-43-7 (S)-2-(N,N-dibenzylamino)-3-phenylpropanoic acid 
• 63-91-2 L-phenylalanine 
• 1402829-75-7 C₃₄H₅₀N₂OSi 
• 118970-37-9 (2S,3S)-3-(dibenzylamino)-2-hydroxy-4-phenylbutanenitrile 
• 100-39-0 benzyl bromide 
• 111060-52-7 (S)-2-(dibenzylamino)-3-phenylpropan-1-ol 
• 127927-43-9 Dibenzyl-((S)-1-oxiranyl-2-phenyl-ethyl)-amine 
• 170359-24-7 (2R,3S)-1-amino-3-(dibenzylamino)-4-phenylbutan-2-ol 
• 244641-41-6 (2R,3S)-3-(dibenzylamino)-1-nitro-4-phenylbutan-2-ol 
• 123054-12-6 (2S)-N,N-dibenzylphenylalaninal 

Downstream Products

• 799241-80-8 N-(3-dibenzylamino-2-hydroxy-4-phenyl-butyl)-N-isobutyl-3-nitro-benzenesulfonamide 
• 1402829-89-3 C₂₅H₃₉N₂O₇PS 
• 1402829-90-6 C₂₉H₄₇N₂O₇PS 
• 1160490-16-3 N-((2R,3S)-3-(dibenzylamino)-2-hydroxy-4-phenylbutyl)-2-(ethyl(methyl)amino)-N-isobutyl-benzo[d]oxazole-6-carboxamide 
• 171370-12-0 N-<3S--2R-hydroxy-4-phenylbutyl>-N'-(1,1-dimethyl-ethyl)-N-(2-methylpropyl)urea 
• 602311-73-9 N-[(2R,3S)-3-(dibenzylamino)-2-hydroxy-4-phenylbutyl]-N-(2-methylpropyl)(4-chloro-3-nitrophenyl)sulfonamide 
• 181289-54-3 N-[3(S)-[-N,N-bis(phenylmethyl)amino]-2(R)-hydroxy-4-phenylbutyl]-N-isobutylamine methanesulfonic acid salt 
• 174391-93-6 N-[3(S)-[N,N-bis(phenylmethyl) amino]-2(R)-hydroxy-4-phenylbutyl]-N-isobutylamine. oxalic acid salt 
• 169280-63-1 3-amino-N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutylbenzenesulfonamide 
• 206362-00-7 {(1S,2R)-1-Benzyl-2-hydroxy-3-[isobutyl-(4-methoxy-benzenesulfonyl)-amino]-propyl}-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester 
• 206361-99-1 darunavir 
• 169280-56-2 4-amino-N-(2R,3S)(3-amino-2-hydroxy-4-phenylbutyl)-N-isobutylbenzenesulfonamide 
• 159005-71-7 N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-methoxybenzenesulfonamide 
• 206361-99-1 darunavir 

Relevant articles and documents

An Efficient Synthesis of a Hydroxyethylamine (HEA) Isostere and Its α-Aminophosphonate and Phosphoramidate Derivatives as Potential Anti-HIV Agents

HIV protease is a promising drug target for AIDS therapy, and several potent HIV-1 protease inhibitors have been reported to date. Although existing inhibitors exhibit high selectivity, they have also been associated with severe side effects and the possi

Self-emulsifying drug delivery system

Oral pharmaceutical formulation which improves the bioavailability of pharmaceuticals which are substantially water and oil insoluble is disclosed. In addition to the pharmaceutical, the formulation includes an emulsifier, an oil and an solubilizer. Alter

Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors

Selected bis-amino acid hydroxyethylamino sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease. The present invention relates to such retroviral protease inhibitors and, more particularly, relates to selected novel compounds, composition and method for inhibiting retroviral proteases, such as human immunodeficiency virus (HIV) protease, prophylactically preventing retroviral infection or the spread of a retrovirus, and treatment of a retroviral infection.